𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection

✍ Scribed by M. J. Williams; M. Lang-Lenton; on behalf of the Trent HCV Study Group


Book ID
108886409
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
194 KB
Volume
18
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Steatosis and progression of fibrosis in
✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

A seven-gene signature (cirrhosis risk s
✍ Moira Marcolongo; Bradford Young; Francesca Dal Pero; Giovanna Fattovich; Laura πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 2 views

Fibrosis progression is the main determinant of liver disease outcome in chronic hepatitis C, being influenced by environmental and host factors. Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To as

Impact of steatosis on progression of fi
✍ Laetitia Fartoux; Olivier ChazouillΓ¨res; Dominique Wendum; Raoul Poupon; Lawrenc πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

In patients with mild hepatitis C, the usefulness of antiviral therapy is subject of debate, as a low risk for progression of fibrosis is assumed. Several studies have shown that steatosis is a strong and independent predictor of the severity as well as the progression of fibrosis in chronic hepatit